|
Market Cap (4-Jul) $8,006,598,144 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (19-Jun) 16,724,445 (4.94%) (48th) |
|
52w High $31.97 |
52w Low $17.03 |
P/E 56.82 |
EPS 0.14 |
TLX released this announcement to the ASX on 16 February 2021, 8:14. The announcement is not marked as price sensitive, and is 1 page(s) in length and 192.08kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.017% short sold according to ASIC data. It was ranked the 536th most shorted stock on the ASX. It is now ranked as the 48th most shorted stock on the ASX with 4.944% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Notification of Conference Call for FY2020 Results | 16 February 2021, 8:14 |
| Collaboration with Heidelberg University Hospital | 10 February 2021, 8:22 |
| Telix Pursues Direct Benelux Product Distribution | 8 February 2021, 8:26 |
| Appendix 3G - issue of unlisted share options | 29 January 2021, 8:49 |
You must be logged in to post a reply.
Telix Pharmaceuticals 